Trial NCT03042312

View at ClinicalTrials.gov 
Org. Study IDs: PSMA-617-02
Secondary IDs: 133661

Last trial update was posted on 2021-03-24

MeSH Interventions

Pluvicto

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Metastatic Castration Resistant Prostate Cancer

Stopping Reasons

Recruitment was stopped before the target sample size was achieved.

Limitations And Caveats

The study began on 05-Jul-17 as an Investigator Initiated Trial and sponsorship was transferred to Endocyte on 01-Jun-18. Recruitment was stopped before the target sample size was achieved based on strategic considerations.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID